Overview

Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis

Status:
Completed
Trial end date:
2019-05-29
Target enrollment:
Participant gender:
Summary
This is a Phase 2a study to evaluate the efficacy and safety of Norketotifen (NKT) in subjects with allergic rhinitis.
Phase:
Phase 2
Details
Lead Sponsor:
Emergo Therapeutics, Inc.
Treatments:
Ketotifen